1. Introduction {#s0005}
===============

Schizophrenia (SZ) and bipolar disorder (BD) are relatively prevalent psychiatric disorders, that cause significant disability ([@bb0080]). The hallmark symptoms of schizophrenia involve psychosis (i.e. delusions or hallucinations), disorganization and negative symptoms; while bipolar disorder classically consists of varying mood episodes, usually involving mania/hypomania and depression. BD shares symptomatic overlap with SZ ([@bb0075]), is prevalent at increased rates in families with SZ ([@bb0210]), and shares chromosomal linkage with SZ ([@bb0130]; [@bb0300]; [@bb0325]). Additionally, at least 50% of those with BP have experienced psychosis in their lifetime ([@bb0075]). While the etiology of both SZ and BP remains elusive, there is accumulating evidence that abnormalities in brain connectivity have a major role in the neurobiology of these disorders.

Diffusion imaging is a powerful non-invasive tool for examining structural brain connectivity based on patterns of water diffusion in neural tissue. With this imaging modality, the diffusion tensor model is most commonly employed, and yields the frequently used fractional anisotropy (FA) measure, which is a measure of the asymmetry of water diffusion, and indirectly indexes "neuronal integrity", putatively reflecting both myelination and organization of the white matter tracts. Diffusion imaging studies in SZ have shown decreased FA in long-range association tracts, including the superior longitudinal fasciculus, cingulum bundle, uncinate fasciculus, inferior longitudinal fasciculus and arcuate fasciculus; projection tracts, such as the anterior thalamic radiation; and the corpus callosum ([@bb0020]; [@bb0205]; [@bb0220]; [@bb0250]; [@bb0310]; [@bb0400]; [@bb0425]). However, there has been a lot of variability in the regions affected across studies, with some reporting no significant abnormalities ([@bb0285]; [@bb0320]; [@bb0425]). Diffusion imaging studies in BD have also shown variable results, with studies reporting decreased FA in a range of white matter tracts ([@bb0245]; [@bb0295]; [@bb0330]), including the corpus callosum ([@bb0445]), and in frontal and temporal regions ([@bb0005]; [@bb0035]; [@bb0045]). Differential results across studies is believed to be influenced by a variety of factors, including disease state, developmental stage, and medications ([@bb0215]; [@bb0310]).

Several methods are available for processing diffusion images, including region-of-interest (ROI), voxel-based and tract-based spatial statistics (TBSS) approaches ([@bb0345]). ROI-based analysis requires a priori delineation of white matter regions, which can be challenging for smaller regions ([@bb0280]), while voxel-based methods can be complicated by inaccuracies with registration algorithms using tensor datasets ([@bb0280]) and have been shown to be very sensitive to differences in processing parameters ([@bb0195]). Recently, TRACULA (TRActs Constrained by UnderLying Anatomy), an automated probabilistic tractography toolbox within Freesurfer ([@bb0430]), was used to segment 18 major white matter tracts in BP and showed decreased FA in multiple tracts, including the superior longitudinal fasciculus, cingulum, and corticospinal tracts ([@bb0190]; [@bb0355]). To our knowledge, TRACULA has not been previously used to investigate white matter tract abnormality in SZ. Studying SZ and BD subjects together using identical imaging protocols, will facilitate the understanding of the relationship and differences of brain connectivity of these disorders. A potential disadvantage of a tract-based approach, such as TRACULA, is that it could dilute the identification of FA abnormalities if these are not present universally across given tracts. Thus, we hypothesize that investigations of white matter integrity would be most informative if tract-based methods are paired with voxel-based approaches, capitalizing on the advantages of each method.

Our current study uses TRACULA and TBSS to investigate the brains of SZ and BP participants, obtained using an optimized diffusion protocol matched to the Young-Adult Human Connectome Project (HCP-YA) ([@bb0350]) and collected on the same customized 'Connectom' scanner as the HCP-YA at Washington University. This scanner was highly modified to improve diffusion imaging, by including a Siemens SC72 gradient coil and stronger gradient power supply with maximum gradient amplitude of 100 mT/m ([@bb0350]). High gradient amplitudes are beneficial for diffusion MRI (dMRI) and increase the signal-to-noise ratio (SNR) over conventional MRI systems ([@bb0350]). We hypothesize that our optimized dMRI protocol will be sensitive to small group differences in white matter integrity. Both groups are hypothesized to show a pattern of decreased FA in multiple tracts, with greater impairment in the schizophrenia group. TBSS is expected to identify the regions with the greatest involvement within these abnormal tracts.

2. Materials and methods {#s0010}
========================

2.1. Subjects {#s0015}
-------------

Participants gave written informed consent prior to participation, and all study protocols were approved by the Institutional Review Board at the Washington University School of Medicine in St. Louis, MO. Imaging data was acquired from 18 to 30-year-old individuals, who were divided into three subject groups: 30 healthy control (CN), 24 schizophrenia (SZ) and 33 bipolar disorder (BD). [Table 1](#t0005){ref-type="table"} shows demographic information. Participant groups were diagnosed on the basis of a consensus between a research psychiatrist and a trained research assistant who used the Structured Clinical Interview for DSM-IV Axis I Disorder ([@bb0110]). CON subjects were required to have no lifetime history of psychotic or mood disorders. Bipolar (BD) participant patients were required to meet DSM-IV criteria for Bipolar I Disorder and were classified as psychotic BD if the participant had a psychotic event over the course of their lifetime, as assessed via the Structured Clinical Interview for the DSM (SCID). Participants were excluded if they: (a) met DSM-IV criteria for substance dependence or severe/moderate abuse during the prior 3 months; (b) had a clinically unstable or severe general medical disorder; or (c) had a history of head injury with documented neurological sequelae or loss of consciousness. Additionally, to minimize clinical heterogeneity within the BD group, only participants with a history of euphoric mania (versus mania characterized by primarily irritable mood) were included in the study.Table 1Baseline demographic and clinical characteristics across participant groups.Table 1CharacteristicCNSZBPF/χ^2^p(n = 30)(n = 24)(n = 33)Age24.5 (3.0)24.6 (3.6)26.5 (3.0)3.90.02Gender (%)7.20.03 Female15 (50.0)5 (20.8)18 (45.5) Male15 (50.0)19 (79.2)15 (54.6)Ethnicity (%)10.00.02 Asian4 (13.3)1 (4.2)3 (9.1) Black7 (23.3)16 (66.7)3 (9.1) Hispanic3 (10.0)03 (9.1) White15 (50.0)5 (16.7)22 (66.7) Other1 (3.3)1 (4.2)1 (3.0)Handedness (%)8.10.23 Left3 (10.0)2 (9.5)3 (9.1) Right27 (90.0)19 (90.5)30 (90.9)Psychotropic medication Hx (%) Typical neuroleptic08 (33.3)2 (6.1) Atypical neuroleptic014 (58.3)12 (36.4)Lithium006 (18.2) Other Mood Stabilizer[b](#tf0015){ref-type="table-fn"}04 (16.7)12 (36.4) SSRI/SNRI1 (3.3)6 (25.0)9 (27.3) Other Antidepressant[a](#tf0010){ref-type="table-fn"}02 (8.3)5 (15.2) Stimulant1 (3.3)00 Benzodiazepines03 (12.5)6 (18.2) Anticholinergic04 (16.7)0 None29 (96.7)4 (16.7)3 (9.1)Duration of Illness (months)N/A72.5 (42.4)119.2 (69.9)N/ASAPS[c](#tf0020){ref-type="table-fn"} Positive symptoms0.07 (0.4)3.42 (2.8)1.03 (1.8)23.4\<0.0001 Disorganization symptoms0.07 (0.4)1.04 (1.5)1.03 (1.7)5.20.007SANS[d](#tf0025){ref-type="table-fn"} Negative symptoms0.7 (1.4)6.25 (3.0)2.88 (3.3)28.4\<0.0001WERCAP[e](#tf0030){ref-type="table-fn"} Mania4.60 (5.7)15.63 (9.3)26.21 (5.9)76.1\<0.0001 Psychosis0.77 (3.2)30.25 (11.2)10.42 (9.3)83.9\<0.0001YMRS0.5 (1.1)1.9 (2.7)3.5 (4.3)7.20.001Stress19.6 (33.5)32.6 (22.7)40.5 (33.4)3.60.03[^1][^2][^3][^4][^5][^6]

Recent symptoms (i.e. in the last two weeks) were assessed using the Scale for the Assessment of Negative Symptoms (SANS), the Scale for the Assessment of Positive Symptoms (SAPS) ([@bb0015]), and the Young Mania Rating Scale (YMRS) ([@bb0440]). Chronic symptoms (i.e. last several years) were assessed using the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) Screen, both mania (mWERCAP) and psychosis (pWERCAP) components ([@bb0165]; [@bb0255], [@bb0265]). Psychosocial stress severity was assessed using the WERC Stress Screen ([@bb0165]; [@bb0255]).

2.2. MRI scan acquisition parameters {#s0020}
------------------------------------

Scans were run using a 32-channel head coil on a customized Siemens 3T "Connectom" MRI scanner, which was previously used for collecting the Human Connectome Project -- Young Adult (HCP-YA) data and housed at Washington University in St. Louis ([@bb0390]). The scanning protocol used identical parameters for individual scans as that of the HCP-YA ([@bb0125]; [@bb0340]; [@bb0390]). However, the overall structure of the HCP-YA protocol was consolidated to 3 total imaging sessions (rather than 4) by only acquiring a single T1-weighted (T1w) and T2-weighted (T2w) scan (rather than two of each). The 3 sessions were typically collected over a period of two days. Briefly, T1w MPRAGE and T2w SPACE images were acquired at 0.7 mm isotropic resolution. Oblique axial acquisitions alternate between right-to-left and left-to-right phase encoding directions in consecutive runs. Image reconstruction used SENSE1 multi-channel ([@bb0350]). A full dMRI session included 6 runs (each approximately 9 min and 50 s), representing 3 different gradient tables, with each table acquired once with right-to-left and left-to-right phase encoding polarities, respectively. Each gradient table includes approximately 90 diffusion weighting directions plus 6 b = 0 acquisitions interspersed throughout each run. Diffusion weighting consisted of 3 shells of b = 1000, 2000, and 3000 s/mm^2^ interspersed with an approximately equal number of acquisitions on each shell within each run. The diffusion directions were obtained using a toolbox available from INRIA that returns uniformly distributed directions in multiple q-space shells. The directions were optimized so that every subset of the first M directions was also isotropic.

2.3. Image preprocessing {#s0025}
------------------------

Diffusion scans were concatenated and run through FSL EDDY (<http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/EDDY>), which reduces distortions caused by eddy currents and subject movement by registering the diffusion weighted images to the *b*~*0*~ image. The *b*~*0*~ image was registered to the T~1~-weighted image with an affine registration. After the distortion correction, the scans were divided to their respective polarities and averaged together. Each individual\'s T~1~-weighted image was registered to the 1 mm-resolution MNI-152 atlas using affine registration ([@bb0185]) in order to compare individual subjects ([@bb0070]). FSL\'s brain extraction tool was used to remove the skull and other non-brain tissue. FSL\'s "dtifit" was applied to perform least-squares tensor estimations, specifically eigenvectors, eigenvalues and FA. "Bedpostx GPU" ([@bb0155]) was used to apply the ball & stick model to estimate diffusion distributions.

2.4. TRACULA {#s0030}
------------

TRACULA (TRActs Contstrained by UnderLying Anatomy) is a powerful method ([@bb0430]) used to analyze global probabilistic tractography. This method uses a Bayesian framework for global tractography suggested by ([@bb0180]) which determines the connection that best fits two selected endpoints using diffusion data. In addition, TRACULA also incorporates prior anatomical knowledge based on manually verified trajectories of tracts in the training set tested by ([@bb0430]). The anatomy of the tracts in the training subject set have been verified to not significantly deviate from those found in Yendiki\'s clinical group ([@bb0430]). For every subject, this method reconstructs probabilistic distributions of 18 major white matter tracts in each subject. A sample participant\'s estimation and identification of white matter tracts is shown in [Fig. 1](#f0005){ref-type="fig"}. More specifically, TRACULA uses the endpoints established in the training set\'s tracts, expands the endpoints, and transforms them into each subject\'s native space. Then, TRACULA establishes probabilistic streamlines accounting for the anatomical Freesurfer segmentations and uses control points to dictate the curvature of the tract. This method does not presume exact tract spatial location or shape, so the trajectory of the tract is only restricted with respect to the surrounding anatomical structures. This allows for individual variations across subjects while still establishing the same tracts for comparison. TRACULA *trac-all* package automates the segmentation steps and includes the training subject data that the manually inspected tract specifications are based on (refer to <https://surfer.nmr.mgh.harvard.edu/fswiki/Tracula> for more details).Fig. 1Depiction of white matter tracts identified by TRACULA in sample control participant. This method determines the connection that best fits between two selected endpoints unique to each (18) white matter tract of interest using diffusion data. Bilateral tracts are given a single color in this figure, but were treated as independent for all analyses.Fig. 1

We analyzed the average Fractional Anisotropy (FA) for all tracts. FA is a commonly used DTI metric that establishes the directional asymmetry of water diffusion at each voxel and total diffusion at each voxel respectively ([@bb0010]; [@bb0050]; [@bb0295]; [@bb0355]). The mean FA for each subject\'s tracts was calculated by TRACULA based on the probabilistic fibers that were at least 20% of the maximum probability fiber for each pathway ([@bb0430]).

2.5. TBSS {#s0035}
---------

Tract-based spatial statistics (TBSS) was used to perform voxel-wise analyses of all white matter tracts, as previously described ([@bb0020]; [@bb0335]). FA images were calculated and projected onto the mean FA skeleton, which represents the center of white matter tracts, and thresholded at FA = 0.2.

2.6. Statistical analysis {#s0040}
-------------------------

All statistical analyses were done using SAS 9.4 (SAS Institute Inc., Cary, NC). For TRACULA studies, analysis of variance, covaried for age and sex, was used to test for diagnostic effects for each tract as well as all pairwise comparisons between diagnostic groups. Tests were Bonferroni corrected for multiple comparisons. Relationships between mean FA for each tract and clinical measures (i.e. SAPS, SANS, YMRS, mWERCAP, pWERCAP, and WERC Stress Screen) were investigated using a forward stepwise multiple linear regression analysis. We performed separate regressions to separately examine the relationship between mean FA and each behavioral variable and report the partial correlation for each significant predictor.

For voxel-wise DTI parameter analyses (i.e. TBSS), groups were compared using general linear models, covarying age and gender. Multiple comparison corrections were applied using a permutation-based statistical approach within FSL\'s Randomise ([@bb0335]). Randomise is FSL\'s tool for nonparametric permutation inference on neuroimaging data, and produces a test statistic image and sets of *P*-value images (stored as 1-P for more convenient visualization, as bigger is then "better"). Brain and behavioral measures which had significant group effects or were abnormal compared to clinical norms were selected for further correlational analysis within the SZ and BD groups, controlling for age and gender. Significance was set at *p* \< .05.

3. Results {#s0045}
==========

3.1. TRACULA group analysis {#s0050}
---------------------------

Mean tract FA in each group, and post-hoc univariate tests for each tract are presented in [Table 2](#t0010){ref-type="table"}. The most notable group differences were seen for the left anterior thalamic radiation (*p* = .039) and the right inferior longitudinal fasciculus (p = .03), with the lowest FA in the SZ group. These differences however did not meet statistical significance after Bonferroni correction.Table 2FA of white matter tracts in control, bipolar disorder and schizophrenia subjects.Table 2TractCONBPDSCZFp(n = 30)(n = 24)(n = 33)Corpus callosumF. Major0.60 (0.07)0.59 (0.07)0.59 (0.08)0.230.79F. Minor0.54 (0.06)0.52 (0.08)0.51 (0.10)0.700.50  Anterior thalamic radiationLeft0.42 (0.04)0.41 (0.03)0.39 (0.06)**3.380.039\***Right0.41 (0.04)0.41 (0.04)0.39 (0.06)1.990.14  Cingular-angular bundleLeft0.37 (0.07)0.40 (0.07)0.37 (0.08)1.700.19Right0.39 (0.08)0.41 (0.07)0.38 (0.08)0.780.46  Cingulum cingulate gyrusLeft0.59 (0.10)0.61 (0.08)0.60 (0.10)0.370.69Right0.54 (0.07)0.54 (0.06)0.53 (0.08)0.120.88  Cortico-spinal tractLeft0.54 (0.04)0.54 (0.04)0.52 (0.06)1.610.21Right0.52 (0.04)0.53 (0.05)0.51 (0.05)0.87  Inferior longitudinal fasciculusLeft0.48 (0.04)0.49 (0.05)0.46 (0.06)2.580.08Right0.48 (0.04)0.50 (0.05)0.46 (0.06)**3.640.03\***  Sup. longitudinal fasc. - parietalLeft0.47 (0.05)0.48 (0.06)0.47 (0.06)0.170.84Right0.47 (0.05)0.47 (0.04)0.45 (0.06)1.340.27  Sup. longitudinal fasc. -- temp.Left0.49 (0.05)0.51 (0.04)0.48 (0.06)1.830.17Right0.47 (0.04)0.47 (0.05)0.46 (0.06)0.610.54  Uncinate fasciculusLeft0.37 (0.07)0.39 (0.07)0.37 (0.08)0.620.54Right0.38 (0.05)0.38 (0.07)0.38 (0.07)0.130.88[^7]

[Fig. 2](#f0010){ref-type="fig"} depicts the z-scored (corrected) mean FA in all tracts across groups and shows a trend for SZ subjects to have lower FA compared to CON and BP participants. BP participants showed a trend towards higher tract FA compared to controls. An ANOVA comparing the 18 average tract z-scores across the three groups showed a significant effect (F = 4.35; *p* = .018). A post-hoc analysis showed significant average z-score differences between SZ and BP (*p* = .01), and trend level differences between SZ vs. CN (*p* = .08). CN vs. BP differences were not significant (*p* = .3).Fig. 2*Z*-Scores of White Matter Tract Fractional Anisotropy obtained from TRACULA. Graphs depict corrected mean FA z-scores of each group\'s white matter tracts, obtained using TRACULA. Z-scores were corrected for gender and age, and subtracted from mean values in the control group. Figures (A) and (B) depict left and right hemispheric structures respectively, with the exception of the corpus callosum (CC) which have major and minor divisions. Plotted values represent means per group. Control = black. Schizophrenia = red. Bipolar disorder = blue. \* *p* \< .05.Fig. 2

3.2. TBSS analysis {#s0055}
------------------

As shown in [Fig. 3](#f0015){ref-type="fig"}A, compared to control subjects, significantly decreased FA was observed in SZ patients largely in the left cerebral hemisphere, unilaterally distributed over the anterior thalamic radiation, posterior thalamic radiation, corticospinal tract and superior longitudinal fasciculi (FDR correction *p* \< .05). Bilaterally decreased FA in the cerebellum was also observed in SZ patients compared to controls.Fig. 3Voxel-based White Matter Fractional Anisotropy Group Comparisons Using TBSS. (A) Schizophrenia vs. Controls. (B) Schizophrenia vs. Bipolar Disorder. Red/orange regions are statistically significant FA differences after FDR correction. Bipolar Disorder vs. Control comparisons are not shown, as no region survived FDR correction.Fig. 3

Compared to controls, FA in bipolar disorder patients were not statistically different. Group FA differences between BP and SZ patients were bilateral and widespread, with decreased FA in SZ patients ([Fig. 3](#f0015){ref-type="fig"}B).

3.3. Clinical relationships: TRACULA {#s0060}
------------------------------------

In order to assess the relationship between clinical variables and FA of TRACULA tracts, across BP and SZ participants, we performed separate stepwise linear regressions for chronic mania (mWERCAP), chronic psychosis (pWERCAP), stress (WERC Stress Screen), recent manic symptoms (YMRS), recent positive symptoms (SAPS), recent disorganization (SAPS), and negative symptoms (SANS), respectively. Among all white matter tracts, the regression for chronic mania identified only the anterior thalamic radiation (ATR) FA as predicting chronic mania severity, accounting for 19.9% of the variance (Β = 38.5; F = 13.7; *p* = .0005). A separate multiple regression showed only the cingulum-angular bundle (CAB) FA significantly predicted recent mania, accounting for 9.3% of the variance (B = 6.7; F = 5.66; *p* = .02). No tract predicted any other behavioral symptom across BP and SZ participants.

Multiple regression analyses were also conducted separately in BP participants (mWERCAP, YMRS) and SZ participants (pWERCAP, SAPS, SANS). In BP, the superior longitudinal fasciculus-temporal (SLF-T) FA predicted chronic mania with 12% of the variance (B = −23.9; F = 4.2; *p* = .049), and the CAB FA predicted recent mania with 12.9% of the variance (B = 9.7; F = 4.6; *p* = .04). In SZ, only the CAB FA predicted chronic psychosis with 23.5% of the variance (B = 29.5; F = 6.8; *p* = .016).

3.4. Clinical relationships: TBSS {#s0065}
---------------------------------

We calculated the relationship between each behavioral measure with FA values across both BP and SZ participants.

Among all behavioral measures, only chronic mania (mWERCAP) correlated with FA, specifically within the left anterior corpus callosum and left anterior thalamic radiation ([Fig. 4](#f0020){ref-type="fig"}). Increased FA was related to increased chronic mania severity.Fig. 4Significant Clinical Relationships with White Matter Fractional Anisotropy in Patients. Figure depicts significant correlations of chronic mania, based on scores from the WERCAP Screen, and FA across bipolar disorder and schizophrenia patients. Red/orange regions show statistically significant FA relationships with chronic mania.Fig. 4

3.5. Medication relationships {#s0070}
-----------------------------

Considering the highly heterogenous medications (and medication combinations) used across our patient populations, completely controlling for medications was not possible. We however investigated the effects of more commonly used medications that have been associated with structural brain changes in select patient groups: 1) typical antipsychotics vs. atypical antipsychotics vs. neither in SZ; 2) lithium vs. no lithium in BP; 3) atypical vs. no atypical in BP; and 4) SSRI/SNRI in BP.

[Fig. 5](#f0025){ref-type="fig"} shows results of individual comparisons and mean tract FA values across groups. Notably, the SSRI/SNRI group trended towards lower mean FA than the non-SSRI/SNRI group, with significant findings observed in the ATR (F = 6.8; *p* = .014); SLF-P (F = 4.3; *p* = .046); SLF-T (F = 4.7; *p* = .039). Group differences did not remain after correcting for multiple comparisons.Fig. 5Medication Effects on TRACULA-Derived White Matter Tracts. Figures depict mean group FA z-scores, corrected for gender and age. Left and right tracks have been combined. (A) schizophrenia patients on either typical antipsychotics, atypical antipsychotics or neither; (B) bipolar disorder patients either on selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) or not; (C); bipolar disorder patients either on lithium or not. \* *p* \< .05.Fig. 5

4. Discussion {#s0075}
=============

We investigated white matter integrity in the brain of patients with schizophrenia and bipolar disorder, scanned with an optimized diffusion imaging protocol identical to that used in the Human Connectome Project ([@bb0350]) and processed using both an automated tract-based approach and a voxel-based approach. With both approaches, we found some significant reduction in white matter tract FA in schizophrenia compared to controls, and a trend towards increased FA in bipolar disorder without meeting statistical significance. The voxel-based approach (TBSS) was better at identifying significant group differences than the tract-based approach (TRACULA) across our participants, likely because the latter dilutes significant group effects if white matter abnormalities are not present across an entire tract. TRACULA did not identify significant group differences (after correcting for multiple comparisons), but showed a trend towards lower FA across several tracts in schizophrenia patients compared to the other participants, most notably in the left anterior thalamic radiation (ATR). TBSS however identified several white matter regions with significantly decreased FA in schizophrenia patients. With the exception of cerebellar white matter, these group differences involved primarily white matter of the left hemisphere. Affected regions included the left ATR, as well as the left posterior thalamic radiation, corticospinal tract and superior longitudinal fasciculus. White matter abnormality is usually found in schizophrenia patients, although with some variability in the affected tracts across studies ([@bb0020]; [@bb0205]; [@bb0220]; [@bb0250]; [@bb0285]; [@bb0320]; [@bb0310]; [@bb0400]; [@bb0425]). A recent meta-analysis of voxel-based morphometry and diffusion imaging studies indicated a widespread white matter disruption in schizophrenia, largely involving the long projection fibers, callosal and commissural fibers, part of motor descending fibers, and fronto-temporal-limbic pathways ([@bb0400]). Meta-analyses of diffusion imaging studies have also reported decreased FA in white coordinates mainly in the deep white matter of the left frontal and temporal brain regions ([@bb0085]). Thus, our findings of widespread white matter involvement, predominantly on the left, is consistent with some prior studies.

We did not find lower FA for any tract in bipolar disorder patients, as observed in prior TRACULA studies ([@bb0190]; [@bb0355]). Rather, the FA of several tracts in the bipolar disorder group trended towards higher values compared to controls, most notably in the cingulum-angular bundle. TBSS analysis also did not show any significant abnormalities in bipolar participant, in contrast to that reported by most other groups ([@bb0295]). Voxel-based studies generally report decreased FA in bipolar individuals in several broad tract categories: fronto-limbic (e.g. the cingulum bundle), interhemispheric (e.g. corpus collosum), and long-distance connections between association cortices (e.g. the superior longitudinal fasciculus) ([@bb0040]; [@bb0150]; [@bb0295]). However, a few studies have reported increased white matter FA in bipolar disorder, suggesting increased directional coherence of certain white matter tracts in some patients ([@bb0245]; [@bb0395]; [@bb0420]). Some studies reporting normal white matter findings in bipolar disorder have involved younger or unmedicated subjects ([@bb0375]), and young adult patients often lack the cortical thinning seen in older cohorts ([@bb0260]), suggesting structural abnormalities progress significantly in some bipolar patients. In addition to the potential role of age, medications likely also influence structural connectivity in bipolar disorder patients. For example, acute antipsychotic use has been associated with increased frontal lobe intracortical myelin volume, while chronic use has been reported as having the opposite effect ([@bb0025]; [@bb0160]). Decreased cingulate and frontal white matter FA in medication naïve bipolar patients after six weeks of risperidone treatment has also been reported ([@bb0415]). In our limited analysis of medication effects, bipolar disorder patients on SSRI-type antidepressants had lower tract FA than those not taking these antidepressants. This may indicate an effect of SSRI on reducing white matter integrity in some tracts. Antidepressant treatment has been associated with improved structural connectivity ([@bb0100]; [@bb0225]; [@bb0240]; [@bb0450]), however decreased white matter structure has also been reported with treatment ([@bb0360]; [@bb0450]). Our results suggest that differential antidepressant use may contribute to variability of findings across studies of white matter in bipolar disorder. In the future, longitudinal diffusion imaging studies of bipolar disorder will be needed to clarify the developmental trajectory of white matter tracts in this disorder and specific medication influences.

A multiple regression identified the cingulum-angular bundle (CAB) FA as predicting recent mania severity in bipolar patients alone, as well as across both patient groups. Interestingly, the CAB FA also predicted chronic psychotic symptoms in patients. In both cases, increased FA in the CAB correlated with increased symptoms. The CAB represents the posterior part of the cingulum, which extends between the posterior cingulate gyrus and the parahippocampus and uncus of the temporal lobe ([@bb0200]). Fibers within this tract have been associated with cognitive functions, conveying memory information from the hippocampus and integrating it with other parts of the brain ([@bb0095]). Decreased structural connectivity of the cingulum, primarily in its anterior part, has been associated with bipolar disorder ([@bb0190]; [@bb0410]), and with mania ([@bb0275]). Our study is the first to our knowledge reporting a positive correlation between cingulum integrity and manic severity, and psychosis in schizophrenia. While speculative, this may reflect enhanced fiber coherence related to prolonged hippocampal and/or amygdala hyperactivity, which has been associated with bipolar disorder ([@bb0145]; [@bb0385]). Decreased FA in the temporal tract of the superior longitudinal fasciculus (SLF-T) also predicted chronic affective symptoms in bipolar patients suggesting that impaired integrity of this tract may be related to the neurobiology of the illness. The SLF is a major association tract in the brain that connects frontal, occipital, parietal and temporal lobes of the brain, and was the only white matter tract shown to have decreased FA in both existing TRACULA studies of bipolar disorder ([@bb0190]; [@bb0355]). Specifically, the impaired SLF-T integrity was also related to psychotic symptoms in one of these studies ([@bb0190]), suggesting this tract may be a marker of illness severity and not of a specific symptom.

The implications of FA abnormalities in disease has been well described. FA measures the asymmetry in the direction of diffusion of water. To the extent that white matter fiber tracts are structurally intact and healthy, the diffusion of water will be dominated by a coherent direction down the path of the fiber tract ([@bb0030]). Axonal degradation, demyelination, and neurodegenerative effects however would be expected to produce a disruption in the coherence of water diffusion and consequently a decrease in the FA. Such findings appear to be largely related to underlying neurobiology of schizophrenia, considering low FA is often seen in medication naïve patients ([@bb0060], [@bb0065]; [@bb0105]; [@bb0115]; [@bb0140]; [@bb0305]; [@bb0365]) and unaffected siblings or high-risk individuals ([@bb0090]; [@bb0315]; [@bb0405]; [@bb0455]). Nevertheless, the effects of confounding factors, including medications and substance use which are prevalent in these patients, may influence the pattern of white matter architecture. Differences in scan acquisition, motion correction, and analysis methods could also contribute to variability across studies. Beyond technical issues and external factors, the biological heterogeneity of schizophrenia likely manifest in differential patterns of brain connectivity, sometimes with differential symptomatology ([@bb0020]; [@bb0365]). For example, by unsupervised biclustering of TBSS-derived white matter data, [@bb0020] identified four general patterns of low FA among schizophrenia subjects, predominantly involving the genu of the corpus callosum; fornix and external capsule; splenium of the corpus callosum; and anterior limb of the internal capsule respectively. Along these lines, [@bb0365] applied hierarchical clustering of 36 features from fiber tracts in schizophrenia patients and found two patterns of abnormalities: one showing widespread white matter abnormalities and another with primarily superior longitudinal fasciculi abnormalities. Thus, it is likely that any given cohort of schizophrenia patients comprises of a highly heterogenous combination of participants, making broad conclusions about specific schizophrenia abnormalities impractical.

There are some limitations in our ability to interpret and extend upon the current findings. Due to the cross-sectional nature of the current study, we cannot address questions of causality in the relationship of observed white matter fractional anisotropy abnormalities. Therefore, this study is unable to address the time course of FA changes with bipolar disorder and cannot specifically rule out the effects of various forms of treatment over the course of the disease. As alluded to above, we also cannot account for all of the potential medication effects on white matter integrity in the current sample, as our study was not well powered to investigate medication effects. For example, many of our patients were taking various mood stabilizers, which could potentially have influenced structural connectivity. Specifically, the neuroprotective effects of mood stabilizing pharmaceuticals may counteract impaired connectivity results differentially throughout the brain in various samples. Lithium, for example, has been associated with the regulation of cell death as well as up-regulation of proteins responsible for axonal myelination, a vital property of cell growth that would directly affect measures of white matter integrity ([@bb0055]; [@bb0270]; [@bb0290]). Antipsychotic medications, used in the treatment of schizophrenia and often bipolar disorder, have been associated with decreased white matter FA ([@bb0370]; [@bb0415]) and volume ([@bb0120]; [@bb0160]), possibly from alterations in glial cell composition or number ([@bb0370]). Indirectly, white matter connectivity could also be affected indirectly, though medication effects on cortical gray matter size ([@bb0230]). Finally, step-wise linear regression may perform poorly with the number of predictors included in cases of collinearity and could give biased coefficients that need shrinkage ([@bb0380]).

In summary, we investigated white matter integrity in schizophrenia and bipolar disorder using two complementary approaches. Both approaches showed reduced white matter FA in schizophrenia, with a trend towards increased FA in bipolar disorder, compared to controls. Specifically, we found decreased FA in multiple, primarily left sided, white matter regions in schizophrenia using TBSS, a voxel-based approach. A tract-based methodology, TRACULA, showed a trend towards lower FA in multiple tracts in schizophrenia, and a trend towards higher FA in some tracts in bipolar disorder. FA in the cingulum-angular bundle predicted chronic mania, and in the superior longitudinal fasciculus predicted recent mania. These studies build on existing studies of psychiatric disorders and show decreased white matter integrity in schizophrenia. Medications, drug use, age and biological heterogeneity are likely confounds, and may have contributed to absence of findings in bipolar patients. Future studies using larger groups are needed, and longitudinal investigations of effects of external factors on structural brain connectivity.
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[^1]: Values are given as means (SD) or number per group (%). Results derived from results of two-way ANOVA or Chi-Square analyses.

[^2]: Refers to antidepressants other than selective serotonin reuptake inhibitors (SSRI).

[^3]: Other mood stabilizers included Tegretol/Carbamazepine, Depakote/Divalproex, Trileptal/Oxcarbazepine, Topomax/Topiramate, and Lamictal/Lamotrigine.

[^4]: Maximum possible score on the Structured Assessment of Positive Symptoms (SAPS) is 16.

[^5]: Maximum possible score on the Structured Assessment of Negative Symptoms (SANS) is 20.

[^6]: WERCAP = Washington Early Recognition Center Affectivity and Psychosis Screen. Maximum possible score on the Mania section is 49. Maximum possible score on the Psychosis section is 64.

[^7]: Bolded and asterisked values are statistically significant.
